{"id":47881,"date":"2022-09-01T11:02:04","date_gmt":"2022-09-01T09:02:04","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/eclinical-solutions-market-report-2022-increasing-externalization-of-clinical-trial-studies-by-large-pharmaceutical-and-biopharmaceutical-companies-driving-growth-researchandmarkets-com\/"},"modified":"2022-09-01T11:02:04","modified_gmt":"2022-09-01T09:02:04","slug":"eclinical-solutions-market-report-2022-increasing-externalization-of-clinical-trial-studies-by-large-pharmaceutical-and-biopharmaceutical-companies-driving-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/eclinical-solutions-market-report-2022-increasing-externalization-of-clinical-trial-studies-by-large-pharmaceutical-and-biopharmaceutical-companies-driving-growth-researchandmarkets-com\/","title":{"rendered":"eClinical Solutions Market Report 2022: Increasing Externalization of Clinical Trial Studies by Large Pharmaceutical and Biopharmaceutical Companies Driving Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “eClinical Solutions Market Size, Share & Trends Analysis Report by Product (eCOA, CTMS, EDC & CDMS), by Delivery Mode (Web-hosted, Licensed Enterprise, Cloud-based), by Development Phase, by End Use, by Region, and Segment Forecasts, 2022-2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global eClinical solutions market size is expected to reach USD 21.8 billion by 2030. The market is expected to expand at a CAGR of 13.6% from 2022 to 2030. Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth.\n<\/p>\n

\nDuring the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage the huge influx of specimens daily. Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years.\n<\/p>\n

\nAs the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development processes are poised to boost market growth over the forecast period. Moreover, digital transformation in the field of clinical trials and preference for data-centric approaches are providing a tremendous push to the market.\n<\/p>\n

\nDemand for integrated clinical IT solutions is increasing due to the massive volume of data generated during clinical development processes. eClinical solutions offer a single source of information that helps optimize the cost by eliminating redundant data entry and by reducing on-site verification and source data verification. Rising awareness regarding these advantages is projected to propel the market.\n<\/p>\n

\nIncreasing adoption of eClinical workflows in trials offers enormous potential in clinical development processes. These solutions can facilitate decision-making in each stage of development. It also helps reduce cost and time between the development phase by utilizing seamless designs and by identifying failing compounds.\n<\/p>\n

\nIn addition, it offers rapid access to data and patient safety information, which helps make quick decisions. Market players engage in new product development and strategic alliances including partnership agreements, promotional activities, and acquisitions to keep market rivalry high. For instance, in October 2020, Oracle entered into collaboration with FHI Clinical Inc. for improving clinical trial efficiency and to get therapies to market faster.\n<\/p>\n

\neClinical Solutions Market Report Highlights<\/strong>\n<\/p>\n